In this issue:
– Twice-yearly lenacapavir for PrEP in men and gender-diverse persons
– Bleeding risk with oral anticoagulants for atrial fibrillation in HIV
– Doxycycline PEP and bacterial STIs among PrEP users
– VTE in people with HIV
– Progress towards UNAIDS 2030 HIV prevention target in NSW
– Mega-ART in treatment experienced people with HIV
– HPV-related dysplasia of oropharyngeal, cervical and anal mucosae in HIV
– Post-AIDS generation of Swedish HIV-negative MSM: perceptions of HIV and stigma
– Food is medicine for HIV
– Loneliness and social isolation in people aged ≥50 years with HIV
Expert contributor
Dr Sarah Metcalf is an Infectious Diseases and General Medicine Physician at Christchurch Hospital. She attended Medical School at the University of Otago, graduating in 1995 and completed post-graduate training at Christchurch Hospital specialising in Infectious Diseases and General Medicine in 2003. Following that she worked in Sheffield, United Kingdom to gain further experience in […]
Expert contributor
Dr Massimo Giola obtained his medical degree in 1991 at the University of Pavia (Italy) and specialised in infectious diseases in 1996 (Italy). He studied antiretroviral drugs’ pharmacokinetics during a PhD programme in clinical and experimental pharmacology from 2005 to 2008 at the University of Varese (Italy). He moved to NZ in 2009 and worked […]
Stay up to date with our latest clinical information.
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.